Former U.S. Senator Ben Sasse said his pancreatic tumors have shrunk by more than 80% [1] after he began taking an experimental clinical-trial drug.
The update comes as the 54-year-old former lawmaker uses his remaining time to issue warnings about the geopolitical and technological stability of the United States.
Sasse, who was diagnosed with Stage 4 inoperable pancreatic cancer [2], discussed his health and his concerns for the country in televised interviews with CNN and a written interview with The New York Times. Despite the significant reduction in tumor size, Sasse noted the severity of his condition. "I am on extended time already," Sasse said [3].
While addressing his medical progress, Sasse pivoted to what he described as existential threats to the nation. He said America faces existential threats from China and artificial intelligence [1]. He believes these two forces represent the most significant risks to the future of the U.S., a perspective he shared alongside his health updates.
Sasse previously announced his diagnosis in December [4]. The current improvement in his condition is attributed to the experimental drug, though he continues to manage a terminal diagnosis. The former Nebraska senator has used his platform to urge a renewed focus on national security and the ethical deployment of AI technology as he navigates his treatment.
“"My tumors have shrunk by more than 80%."”
Sasse's experience highlights the potential of experimental oncology trials to provide significant tumor reduction even in inoperable Stage 4 cases. Simultaneously, his decision to link a personal health crisis with a national security warning underscores a strategic attempt to leverage his visibility to bring urgency to the debate over AI governance and US-China relations.
